Theravance Biopharma (TBPH) Non-Current Debt (2018 - 2022)
Theravance Biopharma (TBPH) posted Non-Current Debt of $396.13 million for Q2 2022, up 5.6% from $375.07 million a year earlier and up 3.1% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Non-Current Debt (2018 - 2022) Analysis & Trends
At the end of FY2021, Theravance Biopharma's Non-Current Debt came in at $371.36 million, down 0.4% from FY2020.
- Annual Non-Current Debt shows a three-year compound annual growth rate of 17.4% (FY2018 to FY2021).
- In prior years, Theravance Biopharma's Non-Current Debt was $372.87 million in FY2020 (+70.0%), $219.3 million in FY2019 (-4.5%) and $229.54 million in FY2018.
- The Q2 2022 figure stands as the highest quarterly Non-Current Debt in data going back to Q4 2018.
- On a year-over-year basis, Non-Current Debt increased in five of the last eight quarters, with growth averaging 18.6%.
- The strongest year-over-year quarter for Non-Current Debt in the past five years was Q3 2020, with growth of 73.2%; the weakest was Q4 2019, with a decline of 4.5%.
- According to Business Quant data, Non-Current Debt for the three prior quarters was $384.16 million (Q1 2022), $371.36 million (Q4 2021) and $375.57 million (Q3 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 396.13 Mn |
| Mar 31, 2022 | 384.16 Mn |
| Dec 31, 2021 | 371.36 Mn |
| Sep 30, 2021 | 375.57 Mn |
| Jun 30, 2021 | 375.07 Mn |
| Mar 31, 2021 | 375.18 Mn |
| Dec 31, 2020 | 372.87 Mn |
| Sep 30, 2020 | 384.48 Mn |
| Jun 30, 2020 | 375.27 Mn |
| Mar 31, 2020 | 373.85 Mn |
| Dec 31, 2019 | 219.30 Mn |
| Sep 30, 2019 | 222.01 Mn |
| Jun 30, 2019 | 217.72 Mn |
| Mar 31, 2019 | 221.40 Mn |
| Dec 31, 2018 | 229.54 Mn |
API Access
Theravance Biopharma Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();